Global Insulin Pumps Industry (2019 to 2027) - Market Trajectory & Analytics - ResearchAndMarkets.com

DUBLIN--()--The "Insulin Pumps - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis and the looming economic recession, the Insulin Pumps market worldwide will grow by a projected US$4.1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 8.4%. Tethered Pumps, one of the segments analyzed and sized in this study, is forecast to grow at over 8.1% and reach a market size of US$4 Billion by the end of the analysis period.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Tethered Pumps market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 9.8% CAGR. Within Europe, Germany will add over US$182.9 Million to the region's size over the next 7 to 8 years. In addition, over US$182.8 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Tethered Pumps segment will reach a market size of US$291.6 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Insulin Pumps market.

Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 8.6% over the next couple of years and add approximately US$627.1 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Insulin Pumps market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Debiotech S.A.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corp.
  • Medtronic Plc.
  • Sooil Development Co. Ltd.
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • Ypsomed Holding AG

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Recent Market Activity
  • Insulin Pumps: A Prelude
  • Key Benefits Offered Infuse Sustained Growth Opportunities
  • Developed Regions Underpin Sales Growth
  • The United States - The Largest Market
  • Europe - A Market with Vast Potential
  • Lower Current Penetration Leaves Significant Room for Growth
  • Rising Incidence of Diabetes - A Major Market Driving Factor
  • Diabetes - Assessing the Economic Burden
  • Global Competitor Market Shares
  • Insulin Pumps Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Type II Diabetes - A Market with Significant Potential
  • Patch Pumps Gain Manufacturer Attention
  • Prefilled Insulin Cartridges Gain Popularity over Manual Filling
  • The Rise of Smart Pumps - A Major Game Changer
  • Innovative Features Spruce Up the Market for Insulin Pumps
  • Artificial Pancreas System (APS) - The Future of Diabetes Care
  • Artificial Pancreas - Are We There Yet?
  • The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps
  • Alarming Rise in Obesity - A Business Case for Diabetes Care
  • Global Obesity Facts in a Nutshell
  • Diabetes in Developing Countries to Expand Opportunities
  • ICR: A Key Factor to Success
  • Customer Satisfaction: Crucial to Stay Competitive
  • Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
  • Undiagnosed Diabetes - A Key Challenge
  • Better Safety Review - A Growing Need for Insulin Pumps
  • Insulin Pump Training - Not Receiving Adequate Attention
  • Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
  • Competition from Other Insulin Delivery Technologies Continues
  • Implantable Insulin Pumps - A Potential Threat to External Insulin Pumps
  • Lantus: A Threat to Insulin Pump Manufacturers

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Total Companies Profiled: 15

For more information about this report visit https://www.researchandmarkets.com/r/1w1nh4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900